The cardiac monitoring products market was valued at $25.1 billion in 2023, and is projected to reach $42.2 billion by 2033, growing at a CAGR of 5.3% from 2024 to 2033.
Cardiac monitoring products are essential tools designed to track and assess heart activities for patients with cardiovascular conditions. These devices provide continuous or on-demand monitoring, enabling early detection of irregularities like arrhythmias, ischemia, or other cardiac events. These devices range from wearable monitors, such as Holter monitors and event recorders, to advanced implantable devices like pacemakers and loop recorders.
The growth of the global cardiac monitoring products market is driven by alarming increase in prevalence of heart-related conditions, such as arrhythmias, heart failure, and coronary artery diseases. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. In addition, surge in geriatric population significantly contributes toward the growth of the global market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases due to degeneration of cardiovascular system. As per the article published by the Revista Española de Cardiología - the official publication of the Spanish Society of Cardiology - coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in public awareness of cardiovascular health and the importance of early detection are encouraging more widespread use of cardiac monitoring products. Moreover, increase in penetration of telemedicine and remote patient monitoring devices has accelerated the adoption of cardiac monitoring devices, which acts as the key driving force of the global market. However, high costs of devices and procedures hamper the market growth. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access restrain the market growth. On the contrary, innovations in wearable technology, remote monitoring, and AI-driven diagnostics are enhancing the functionality and accessibility of cardiac monitoring devices, which are expected to offer lucrative opportunities for the market growth during the forecast period. Furthermore, higher healthcare spending, particularly in emerging markets, is driving investments in advanced medical technologies, including cardiac monitoring devices, which is anticipated to open new avenues for the market growth.
The cardiac monitoring products industry is segmented into device type, application, end user, and region. By device type, the market is divided into ECG monitor, event recorder, implantable cardiac loop recorder, pacemaker, defibrillator, cardiac resynchronization therapy (CRT) devices, smart wearable, and others. On the basis of end user, it is divided into hospitals, specialty clinics, ambulatory care, homecare, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
On the basis of end user, the hospital segment was the major shareholder in 2023.
Region wise, North America held a dominant position in the market; however, Asia-Pacific is expected to register highest CAGR during the forecast period.
Cardiac monitoring products are essential tools designed to track and assess heart activities for patients with cardiovascular conditions. These devices provide continuous or on-demand monitoring, enabling early detection of irregularities like arrhythmias, ischemia, or other cardiac events. These devices range from wearable monitors, such as Holter monitors and event recorders, to advanced implantable devices like pacemakers and loop recorders.
The growth of the global cardiac monitoring products market is driven by alarming increase in prevalence of heart-related conditions, such as arrhythmias, heart failure, and coronary artery diseases. According to the World Heart Federation, cardiovascular diseases are the leading cause of death worldwide as compared to any other cause. Approximately 20.5 million die every year due to cardiovascular diseases. In addition, surge in geriatric population significantly contributes toward the growth of the global market. This is attributed to the fact that aged individuals are highly susceptible to cardiac diseases due to degeneration of cardiovascular system. As per the article published by the Revista Española de Cardiología - the official publication of the Spanish Society of Cardiology - coronary heart disease is the leading cause of death in 81% of adults aged 65 years or older. Furthermore, increase in public awareness of cardiovascular health and the importance of early detection are encouraging more widespread use of cardiac monitoring products. Moreover, increase in penetration of telemedicine and remote patient monitoring devices has accelerated the adoption of cardiac monitoring devices, which acts as the key driving force of the global market. However, high costs of devices and procedures hamper the market growth. Moreover, lack of appropriate health facilities to meet population needs in most countries and limited access restrain the market growth. On the contrary, innovations in wearable technology, remote monitoring, and AI-driven diagnostics are enhancing the functionality and accessibility of cardiac monitoring devices, which are expected to offer lucrative opportunities for the market growth during the forecast period. Furthermore, higher healthcare spending, particularly in emerging markets, is driving investments in advanced medical technologies, including cardiac monitoring devices, which is anticipated to open new avenues for the market growth.
The cardiac monitoring products industry is segmented into device type, application, end user, and region. By device type, the market is divided into ECG monitor, event recorder, implantable cardiac loop recorder, pacemaker, defibrillator, cardiac resynchronization therapy (CRT) devices, smart wearable, and others. On the basis of end user, it is divided into hospitals, specialty clinics, ambulatory care, homecare, and others. Region wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Key Findings
By device, the ECG monitor segment dominated the market, in terms of share, in 2023.On the basis of end user, the hospital segment was the major shareholder in 2023.
Region wise, North America held a dominant position in the market; however, Asia-Pacific is expected to register highest CAGR during the forecast period.
Competition Analysis
Competitive analysis and profiles of the major players in the global cardiac monitoring products market include Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, GE Healthcare, iRhythm Technologies Inc, Biotronik, LivaNova PLC, Baxter International Inc., Schiller AG, and Koninklijke Philips N.V. These major players have adopted various key development strategies such as business expansion, new product launches, and partnerships to sustain the intense competition and gain a strong foothold in the global market.Additional benefits you will get with this purchase are:
- Quarterly Update and* (only available with a corporate license, on listed price)
- 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
- Free Upcoming Version on the Purchase of Five and Enterprise User License.
- 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
- 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
- Free data Pack on the Five and Enterprise User License. (Excel version of the report)
- Free Updated report if the report is 6-12 months old or older.
- 24-hour priority response*
- Free Industry updates and white papers.
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)
- Regulatory Guidelines
- Additional company profiles with specific to client's interest
- Additional country or region analysis- market size and forecast
- Expanded list for Company Profiles
- Historic market data
- Key player details (including location, contact details, supplier/vendor network etc. in excel format)
Key Market Segments
By Device Type
- ECG monitor
- Event Recorder
- Implantable Cardiac Loop Recorder
- Pacemaker
- Defibrillator
- Cardiac Resynchronization Therapy (CRT) Devices
- Smart Wearable
- Other
By End User
- Hospitals
- Specialty Clinics
- Ambulatory Care
- Homecare
- Other
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- Australia
- India
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
Key Market Players
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- GE Healthcare
- iRhythm Technologies Inc
- Biotronik
- LivaNova PLC
- Baxter International Inc.
- Schiller AG
- Koninklijke Philips N.V.
Please note:
- Online Access price format is valid for 60 days access. Printing is not enabled.
- PDF Single and Enterprise price formats enable printing.
Table of Contents
CHAPTER 1: INTRODUCTION
CHAPTER 2: EXECUTIVE SUMMARY
CHAPTER 3: MARKET LANDSCAPE
CHAPTER 4: CARDIAC MONITORING PRODUCTS MARKET, BY DEVICE TYPE
CHAPTER 5: CARDIAC MONITORING PRODUCTS MARKET, BY END USER
CHAPTER 6: CARDIAC MONITORING PRODUCTS MARKET, BY REGION
CHAPTER 7: COMPETITIVE LANDSCAPE
CHAPTER 8: COMPANY PROFILES
LIST OF TABLES
LIST OF FIGURES
Companies Mentioned
- Abbott Laboratories
- Medtronic plc
- Boston Scientific Corporation
- GE Healthcare
- iRhythm Technologies Inc
- Biotronik
- LivaNova PLC
- Baxter International Inc.
- Schiller AG
- Koninklijke Philips N.V.
Methodology
The analyst offers exhaustive research and analysis based on a wide variety of factual inputs, which largely include interviews with industry participants, reliable statistics, and regional intelligence. The in-house industry experts play an instrumental role in designing analytic tools and models, tailored to the requirements of a particular industry segment. The primary research efforts include reaching out participants through mail, tele-conversations, referrals, professional networks, and face-to-face interactions.
They are also in professional corporate relations with various companies that allow them greater flexibility for reaching out to industry participants and commentators for interviews and discussions.
They also refer to a broad array of industry sources for their secondary research, which typically include; however, not limited to:
- Company SEC filings, annual reports, company websites, broker & financial reports, and investor presentations for competitive scenario and shape of the industry
- Scientific and technical writings for product information and related preemptions
- Regional government and statistical databases for macro analysis
- Authentic news articles and other related releases for market evaluation
- Internal and external proprietary databases, key market indicators, and relevant press releases for market estimates and forecast
Furthermore, the accuracy of the data will be analyzed and validated by conducting additional primaries with various industry experts and KOLs. They also provide robust post-sales support to clients.
LOADING...
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 280 |
| Published | July 2024 |
| Forecast Period | 2023 - 2033 |
| Estimated Market Value ( USD | $ 25.1 billion |
| Forecasted Market Value ( USD | $ 42.2 billion |
| Compound Annual Growth Rate | 5.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
